Hepcidin regulates iron metabolism by down-regulating ferroportin-1 (Fpn1). We demonstrated that hepcidin is complexed to the blood transport protein, α 2 -macroglobulin (α 2 M) (Peslova, G., Petrak, J., Kuzelova, K., Hrdy, I., Halada, P., Kuchel, P. W., Soe-Lin, S., Ponka, P., Sutak, R., Becker, E., Huang, M. L., Suryo Rahmanto, Y., Richardson, D. R., and Vyoral, D. (2009) Blood 113, 6225–6236). However, nothing is known about the mechanism of hepcidin binding to α 2 M or the effects of the α 2 M·hepcidin complex in vivo . We show that decreased Fpn1 expression can be mediated by hepcidin bound to native α 2 M and also, for the first time, hepcidin bound to methylamine-activated α 2 M (α 2 M-MA). Passage of high molecular weight α 2 M·hepcidin or α 2 M-MA·hepcidin complexes (≈725 kDa) through a Sephadex G-25 size exclusion column retained their ability to decrease Fpn1 expression. Further studies using ultrafiltration indicated that hepcidin binding to α 2 M and α 2 M-MA was labile, resulting in some release from the protein, and this may explain its urinary excretion. To determine whether α 2 M-MA·hepcidin is delivered to cells via the α 2 M receptor (Lrp1), we assessed α 2 M uptake and Fpn1 expression in Lrp1 −/− and Lrp1 +/+ cells. Interestingly, α 2 M·hepcidin or α 2 M-MA·hepcidin demonstrated similar activities at decreasing Fpn1 expression in Lrp1 −/− and Lrp1 +/+ cells, indicating that Lrp1 is not essential for Fpn1 regulation. In vivo , hepcidin bound to α 2 M or α 2 M-MA did not affect plasma clearance of α 2 M/α 2 M-MA. However, serum iron levels were reduced to a significantly greater extent in mice treated with α 2 M·hepcidin or α 2 M-MA·hepcidin relative to unbound hepcidin. This effect could be mediated by the ability of α 2 M or α 2 M-MA to retard kidney filtration of bound hepcidin, increasing its half-life. A model is proposed that suggests that unlike proteases, which are irreversibly bound to activated α 2 M, hepcidin remains labile and available to down-regulate Fpn1. Background: Hepcidin is the hormone of iron metabolism that is bound by α 2 -macroglobulin (α 2 M) and its activated counterpart (α 2 M-MA). Results: Serum iron is reduced to a greater extent in mice treated with α 2 M·hepcidin or α 2 M-MA·hepcidin relative to unbound hepcidin. Conclusion: α 2 M retards hepcidin excretion by the kidney, increasing its efficacy. Significance: These results are important for understanding hepcidin transport and detection in blood.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: